Monkeypox Virus Detection By Seegene PCR Test: An assay that is focused on the monkeypox virus can produce results in 90 minutes.
Using its automated assay development approach, the company quickly introduces new products.
“Seegene will try to provide accurate tests for emerging viruses to help avert future pandemics,” says the company.
Follow chopnews to get more updates
Seegene develops PCR test to detect monkeypox virus
28 June 2022, SEOUL, South Korea /PRNewswire — The top molecular diagnostics (MDx) business in South Korea, Seegene, Inc. (KQ965390), has created a PCR test to identify the monkeypox virus.
The company’s SGDDS (Seegene Digitalized Development System) AI-based automated test development system and technologies honed over 20 years of MDx expertise were used to quickly develop the NovaplexTM MPXV Assay, which specifically targets the monkeypox virus.
The World Health Organization urges its member states to intensify surveillance, contact tracing, and testing because the monkeypox virus is a “evolving health danger that demands collective attention and concerted response.”
Over 50 countries have reported monkeypox virus detection, and South Korea confirmed its first case last week.
The strain that is presently spreading in the Northern Hemisphere is particularly harmful for youngsters and others with weakened immune systems, with an estimated death rate of between 3 and 6 percent.
Accurate diagnosis is essential since therapies work best when an illness is caught early, as is the case with many infectious diseases.
Given that the incubation period for the monkeypox virus can last anywhere between five and 21 days, prompt PCR testing is essential, especially for people who have a suspected case.
In 90 minutes, the NovaplexTM MPXV Assay can determine whether a patient has the monkeypox virus.
To assist stop the spread across the globe, the company quickly produced the product. The assays will be made available by Seegene to nations that have found the virus.
The monkeypox virus epidemic, according to Dr. Jong-Yoon Chun, CEO of Seegene, “shows that endemic viruses can rapidly spread to the rest of the world and is a warning that new pandemics can emerge and threaten human lives at any time.”
“We will keep working to build tools that can precisely diagnose any virus to help stop emerging infectious illnesses from spreading and becoming pandemics,” the statement reads.